Stocky turns companies like JAPAN ANIMAL REFERRAL MED CNTR into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. 6039.T shows solid Growth Compounder credentials (70.3/100 driven by mid-teens revenue expansion), but Value Compounder weakness (45/100) and moderate Leadership Alignment (52/100) signal uneven capital discipline. While the Vulnerability Profile flags no structural moat concerns, the 13.2x forward multiple leaves limited margin of safety relative to execution risk. Suitable for patient holders; better opportunities exist elsewhere.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for JAPAN ANIMAL REFERRAL MED CNTR :
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 47/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates JAPAN ANIMAL REFERRAL MED CNTR (6039.T) at 47/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. 6039.T shows solid Growth Compounder credentials (70.3/100 driven by mid-teens revenue expansion), but Value Compounder weakness (45/100) and moderate Leadership Alignment (52/100) signal uneven capital discipline. While the Vulne
6039.T's current Stocky Verdict is 47/100, placing it in the "Cautious" band. This composite combines a 70/100 Compounder score, 52/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for JAPAN ANIMAL REFERRAL MED CNTR yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
JAPAN ANIMAL REFERRAL MED CNTR scores 52/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
JAPAN ANIMAL REFERRAL MED CNTR 's Vulnerability Profile scores 0/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to JAPAN ANIMAL REFERRAL MED CNTR .
Sign up free and unlock the full analysis on 6039.T — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for 6039.T in the app.
